Pricing Log in Create free account

Avenue Therapeutics, Inc. (ATXI) vs SciSparc Ltd. (SPRC)

Avenue Therapeutics, Inc. and SciSparc Ltd. are both Biotechnology companies. SciSparc Ltd. is the larger, with a market value of $880.0K against $680.0K — 1.3× the size. Across the 9 metrics below, Avenue Therapeutics, Inc. leads on 6 and SciSparc Ltd. on 3.

Valuation

Metric ATXI SPRC Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 2.49 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.05 0.13 0.66
EV/Sales n/m n/m 9.02
Earnings yield (197.67%) (17,380.49%) (32.88%)
Free cash flow yield (97.68%) (160,955,097.92%) (23.13%)

Profitability

Metric ATXI SPRC Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.30%) 0.00% (51.96%)
Return on assets (90.50%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATXI SPRC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 94.11% 51.90% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATXI SPRC Biotechnology median
Debt to equity 0.00 0.24 0.00
Current ratio 1.40 0.87 4.97
Net debt to EBITDA 0.93 0.52 1.01

Dividend

Metric ATXI SPRC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ATXI SPRC Biotechnology median
Market cap 680.00k 880.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack